Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study.

Gregson, John; Kaleebu, Pontiano; Marconi, Vincent C; van Vuuren, Cloete; Ndembi, Nicaise; Hamers, Raph L; Kanki, Phyllis; Hoffmann, Christopher J; Lockman, Shahin; Pillay, Deenan; +9 more... de Oliveira, Tulio; Clumeck, Nathan; Hunt, Gillian; Kerschberger, Bernhard; Shafer, Robert W; Yang, Chunfu; Raizes, Elliot; Kantor, Rami; Gupta, Ravindra K; (2016) Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. The Lancet infectious diseases, 17 (3). pp. 296-304. ISSN 1473-3099 DOI: https://doi.org/10.1016/S1473-3099(16)30469-8

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S1473-3099(16)30469-8

Abstract

Share

Download

Filename: Occult HIV-1 drug resistance to_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar